These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial. Cay S, Canpolat U, Ucar F, Ozeke O, Ozcan F, Topaloglu S, Aras D. Am J Cardiol; 2015 May 01; 115(9):1235-43. PubMed ID: 25765588 [Abstract] [Full Text] [Related]
18. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Circ Arrhythm Electrophysiol; 2014 Feb 01; 7(1):164-70. PubMed ID: 24446023 [Abstract] [Full Text] [Related]